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ABSTRACT 
Although acute pulmonary toxicity of carbon nanotubes (CNTs) has been extensively 
investigated, the knowledge of potential health effects following chronic occupational 
exposure is currently limited and based only upon in vivo approaches. Our aim was to 
realistically mimic sub-chronic inhalation of multi-walled CNTs (MWCNTs) in vitro, using 
the Air-Liquid Interface Cell Exposure system (ALICE) for aerosol exposures onto 
reconstituted human bronchial tissue from healthy and asthmatic donors. The reliability and 
sensitivity of the system was validated using crystalline quartz (DQ12), which elicited an 
increased (pro-)inflammatory response, as reported in vivo. At the administrated MWCNT 
doses relevant to human occupational lifetime exposure (10µg/cm² for five weeks of repeated 
exposures/five days per week) elevated cilia beating frequency (in both epithelial cultures) 
and mucociliary clearance (in asthmatic cells only) occurred, whereas no cytotoxic reactions 
or morphological changes were observed. However, chronic MWCNT exposure did induce an 
evident (pro-)inflammatory and oxidative stress response in both healthy and asthmatic cells. 
The latter revealed stronger and more durable long-term effects compared to healthy cells, 
indicating that individuals with asthma may be more susceptible to adverse effects from 
chronic MWCNT exposure. Our results highlight the power of occupationally-relevant sub-
chronic exposures onto human in vitro models in nanosafety hazard assessment.  
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The high aspect ratio, excellent strength and good conductivity offered by carbon nanotubes 
(CNTs) has raised their demand in the global industry market.1 However,  recent studies 
provided evidence that CNTs can be released during the manufacturing process, and both 
scientific and public concern has been raised regarding the potential risks to human health.2,3 
Recently, the levels of human occupational exposure were assessed in different departments 
of a commercial manufacturing facility in the Netherlands, and concentrations up to 41-
43µg/m3 were measured in the production and handling area, whereas in offices and research 
departments the levels were almost 10 times lower.4 In addition, Shvedova and colleagues 
compared the mRNA and ncRNA expression profiles in the blood of exposed workers (with 
at least six months direct contact with aerosolised MWCNTs) and non-exposed employees of 
the same production facility. Results revealed significant changes in gene expression 
associated with cell-cycle regulation, apoptosis and proliferation, with potential pulmonary, 
cardiovascular and carcinogenic risk in MWCNT-exposed humans.5  
The extremely high aspect ratio and biopersistence of MWCNTs poses a major concern that 
fiber inhalation in the workplace might induce unwanted pulmonary effects which resemble 
the serious effects of micron-sized asbestos fibers.6 A growing number of animal studies have 
demonstrated that MWCNT inhalation is a highly potent trigger for the onset of airway injury, 
inflammation, fibrosis and granuloma formation.7-9 Once inhaled, MWCNTs can reach the 
deepest regions of the respiratory tract – the bronchioles-alveolar region – where they are not 
rapidly degraded but accumulate in the lower lung and distributed to other organs over a 
period of 90-336 days (d). 10,11 
Most in vivo studies do not take into consideration the real concentrations in an occupational 
setting and as a consequence cannot be extrapolated to human exposure.12 	Since exposure in 
manufacturing facilities most probably occurs repeatedly over a long timeframe, it is crucial 
to obtain insight into the pulmonary toxicity of chronic CNT exposure to repeated doses that 
closely resemble realistic occupational exposure conditions. Many studies addressing possible 
adverse effects of CNTs were performed on animal-based approaches, however, there is a 
clear need to circumvent these time-consuming, cost-intensive and ethically problematic in 
vivo studies. In addition, detailed insight into the mechanistic interaction of CNTs with cells 
(i.e. toxicodynamics) is difficult to obtain in vivo. Most existing in vitro studies focusing on 
acute or long-term exposures were carried out using relatively high doses and under 
submerged conditions, despite such exposure conditions having little physiological relevance 
to the investigation of pulmonary effects since lung cells are exposed to air on their apical 
surface.13-16 Consequently, these findings cannot be correlated with the outcomes of in vivo 
chronic studies, thus illustrating the critical necessity for an advanced in vitro strategy to 
realistically and reliably assess the biological consequences of CNTs following long-term 
repeated administration.  
In the past various reports have indicated the attribution of occupational and environmental 
factors in the modulation of lung airway diseases. In particular, the role of NPs in 
exacerbation of pulmonary diseases has been confirmed in environmental studies.17 A limited 
number of studies, have also demonstrated that engineered NPs i.e. titanium, gold or silica 
NPs, could have a respiratory exacerbation effect in animal models with pre-existing 
respiratory diseases i.e. asthma.18,19 Indeed, asthma is a highly prevalent and significant 
chronic inflammatory airway disease, primarily characterised by bronchial obstruction, 
affecting 235 million people worldwide.20 The lack of investigation on the impact of NP 
inhalation on patients with pulmonary diseases is of importance, considering that workers in 
NP production facilities are likely to suffer from respiratory illnesses. 
To address the aforementioned needs, the aim of the present study was to mimic the chronic 
inhalation of MWCNTs in vitro, by using the Air-Liquid Interface Cell Exposure system 
(ALICE) system21 to induce repeated MWCNT aerosol exposure onto primary human 
bronchial epithelial cells cultured at the air-liquid interface (ALI) at low, realistic doses 
corresponding to human occupational lifetime exposure (Figure 1). Potential susceptible 
effects in repeatedly exposed asthmatic cells were also investigated, since it has been shown 
in vivo that CNTs may act as an exacerbating factor in animals with pre-existing lung 
disorders, particularly asthma.22,23 However, limited information is still available regarding 
the impact of CNTs on asthmatic mice models, and to date there has been no in vitro report 
questioning the consequences of MWCNTs exposures in primary lung cell cultures derived 
from asthmatic donors.  
 
 
 
 
 
 
 
RESULTS AND DISCUSSION 
Aerosolisation of MWCNTs and deposition characterization 
The ALICE is a well-established aerosolisation system for spherical nanoparticles21, 24 and 
was recently demonstrated to be efficient for the aerosolisation of fiber-shaped nanomaterials, 
such as cellulose nanocrystals and MWCNTs for single and short-term repeated 
exposures.25,26 For the current study a stable, well-characterised and well-dispersed 
MWCNT27 suspension was aerosolised using the ALICE. For the current work Pluronic F127 
has been used as a dispersant since it prevents tube aggregation during the experimental work-
procedure and results in well-dispersed suspension allowing an efficient aerosolisation.25, 27 
Pluronic is biocompatible and frequently used in galenics 28, and since it is a non-ionic 
detergent, it is rapidly displaced by proteins and lipids contained in the surfactant layer on top 
of the epithelial cultures under experimental conditions, similar to the in vivo  situation 
following CNT inhalation.29 MWCNTs were thoroughly characterised prior to and after the 
aerosolisation process, as described in previous work.25, 27, 30 The size distribution of the stock 
and deposited MWCNTs, as well as all other key physicochemical characteristics of the 
MWCNT sample are summarized in Supplementary Table 1. Both transmission electron 
microscopy (TEM) and scanning electron microscopy (SEM) revealed the typical tubular 
structure of aerosolised MWCNTs (Figure 2a-b, SI Figure 1). Visualisation of deposited 
MWCNTs following single and several repeated exposures revealed a reproducible, 
homogenous and dose-dependent deposition. Furthermore, in our earlier study it was shown 
that the aerosolisation process did not affect the morphology of the deposited tubes, as no 
MWCNT fracture or damage was observed compared to the fibers in stock suspension.25 
Hence, the ALICE reflects an effective and reproducible approach to study the long-term 
inhalation of MWCNTs in vitro.    
 
Figure 1: Schematic presentation of the exposure scenario. Cell cultures were exposed for 
up to five weeks, five days per week to aerosolised MWCNTs using the ALICE system. The 
cellular response following MWCNT exposure was analyzed at the end of w1, w3 and w5. 
 
Single aerosolisation of 250µg/ml MWCNTs resulted in an average deposited value of 
0.39±0.05µg/cm2. Repeated MWCNTs nebulisations revealed deposited doses of 1.95±0.07, 
5.76±0.056 and 9.58±0.054µg/cm2 for week (w) 1, w3 and w5 time-points, respectively 
(Figure 2c). The selected deposited dose in our experiments can be considered relevant to a 
human occupational lifetime exposure. In particular, the alveolar mass retention of a full 
working lifetime exposure (45 years) to CNTs of different sizes was modelled and calculated 
to be in the range of 12.4 to 46.5µg/cm2.31  Based on these findings, the highest deposited 
dose in the present study (10µg/cm2) reached after five weeks of repeated exposure reflects a 
full working lifetime human exposure to MWCNTs. It is worthwhile to mention, that the 
calculation in the applied dosimetry model has been based on alveolar mass deposition. 
However, to the best of our knowledge this is the only existing model to predict realistic 
CNTs doses upon long-term occupational settings.  Although bronchial epithelial surfaces 
may not receive the same amount of deposited CNTs, however, a large portion of the 
deposited particles will be cleared by the mucociliary clearance mechanism. Therefore, the 
applied doses are considered highly realistic. 
 
 
 	 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: MWCNT morphology and deposition upon repeated aerosol exposures. TEM 
images of deposited MWCNTs (a) after single (d1) and (b) after five repeated aerosolisations 
(w1) using the ALICE system (Scale bars: 2µm). Inset shows higher magnification image of 
aerosolised MWCNTs after single exposure (scale bar: 1µm).	(c) Average deposition (µg/cm
2
) 
of MWCNTs and DQ12 as measured by QCM at different tested time-points (n=3). 
The deposition for the negative control (ultrapure H2O) was below the detection limit 
(0.09µg/cm2) of the integrated Quartz Crystal Microbalance (QCM). Moreover, exposure to 
aerosolised crystalline quartz, i.e. DQ12, demonstrated an average deposited dose of 
0.23±0.07µg/cm2 and also resulted in a dose-dependent increase at repeated exposures.  
 
Cell morphology and functionality 
The airway epithelial cells, together with macrophages, constitute the first line of cellular 
defense against external antigens, i.e. inhaled nanomaterials, allergens or chemicals.32 
Undoubtedly, the presence of immune cells i.e. primary macrophages and dendritic cells in 
the culture would enhance the structural resemblance to the native lung state and would 
further give the possibility to investigate the cellular interplay.	However, the short lifetime (up 
to twelve days from the isolation) of primary immune cells (data not shown) remains a 
limitation in chronic experimental settings and more research is required to extend the 
a b 
c 
survival of primary immune cells to allow long-term toxicity testing. Taking into account the 
difficulties and challenges to simulate a chronic repeated experimental setting in vitro, an 
effective and sensitive methodology was applied for long-term dose-controlled aerosolisation 
of fiber-based nanomaterials directly at the cells surface resembling the physiological 
situation in the lungs as realistic as possible. Despite the limitations of the in vitro model and 
although it is impossible to fully represent the complexity of the human respiratory system, it 
contains important features, that are valuable for inhalation safety assessment studies, 
sometimes even more than the whole animal experiments. In addition, by using a positive 
particle control i.e. DQ12, we have shown that the model is sensitive to an inflammatory 
stimulus and also reflects in vivo findings. 
The crucial role of lung epithelium in initiating respiratory responses was further supported in 
a recent study, which demonstrated that carbon nanoparticle (NP)-induced inflammation is an 
epithelial-dependent process, with no macrophage involvement.33  Indeed, it is well-accepted 
that the airway epithelium controls the recruitment and activation of immune cells and 
regulates inflammatory reactions through the release of a vast array of cytokines,  that play a 
central role in the pathogenesis of most pulmonary diseases, including asthma.34 Notably, an 
important defense mechanism of the bronchial epithelium is the secretion of mucus that 
potentially traps the majority of inhaled nanomaterials and microorganisms and eliminates 
them by the cooperative function of mucociliary clearance (MCC) and cilia beating.35 In order 
to simulate in vivo lung conditions in the present study, fully differentiated primary bronchial 
epithelium derived from healthy (no reported lung pathology) or asthmatic donors were used. 
This cellular model consists of a pseudo-stratified structure of basal, ciliated and mucus-
producing cells, therefore possessing an active protective MCC mechanism. In addition, it 
allows long-term repeated dose toxicity testing.  
One of the advantages of human primary cell cultures is that they retain the enzymatic, 
protein and signaling pathways of the native tissue.36 Indeed, recent studies provided evidence 
that reconstituted asthmatic bronchial epithelial cells maintain in culture their 
intrinsic/epigenetic, if not genetic characteristics, such as the Granulocyte-Macrophage 
Colony-Stimulating Factor (GM-CSF) activity.37,38 The production of GM-CSF, a key 
cytokine involved in asthma pathogenesis is much higher in bronchial epithelial cells derived 
from biopsies of asthmatic people compared to healthy control tissues.37 GM-CSF release 
therefore was assessed to confirm that the employed asthma tissues retain their asthmatic 
phenotype. As shown in SI Figure 2, asthmatic cultures showed significant GM-CSF release 
compared to healthy tissues, thus highlighting their ability to maintain their asthmatic 
phenotype within the experimental approach. 
It should be noted that the use of primary cells from different donors inevitably increased the 
variation in biological responses across four independent replicates. The standard deviation 
could not be reduced by increasing the number of experimental repetitions as the variation of 
four experiments was similar to the n of three, which confirms that the reported variability is 
most likely an intrinsic characteristic of the obtained data set and not due to a small sample 
size. However, and importantly, such donor-dependent variation is highly reflective of the 
heterogeneity in the human population and therefore can be considered to be indicative of a 
real-world situation.39 
Conventional light microscopy images of reconstituted human bronchial epithelial cells upon 
exposure to MWCNTs revealed no signs of modification in cellular morphology, although 
increased MWCNT accumulation was observed on the cell surface over weeks of exposure 
(Figure 3a-b, SI Figure3). Furthermore, TEM micrographs of the bronchial epithelial tissue 
revealed that MWCNTs were internalised by both healthy and asthmatic cultures. In 
particular, MWCNTs were observed within vesicular structures either as single tubes or as 
small agglomerates (Figure 3a´-b´).		
Importantly, following five weeks of repeated MWCNT exposures, the epithelial cell layer 
structure was maintained, without ruptures or signs of apoptosis (i.e. fragmented cell nuclei or 
cellular blebbing). Moreover, no observed modifications in tight junctions or cilia formation 
were noted compared to negative control cultures over the analysed period. 
 
 
 
Figure 3: Morphological assessment of healthy and asthma cultures and MWCNT 
uptake after sub-chronic repeated exposure. Light microscopy images of healthy (a) and 
asthmatic (b) cultures at w5. White arrows indicate MWCNTs accumulated in the cells 
surface (scale bars: 100µm). TEM micrographs of internalised MWCNTs in healthy (a´) and 
asthmatic (b´) bronchial epithelial cells at w5 (scale bars: 2µm at lower magnification images 
and 500nm at higher magnification images). Black arrows indicate the position of MWCNTs. 
 
No alterations to the cytoskeleton and nuclei were evident in Laser Scanning Microscopy 
(LSM) images in either healthy or asthmatic cultures following repeated exposures to 
MWCNTs for up to five weeks when compared to control cultures (Figure 4a, SI Figure 4).  
No induction of cytotoxic reactions was reported for either healthy or asthmatic cells after 
MWCNT exposures at w1 and w3 (Figure 4b), supporting the microscopy data. However, a 
slight but insignificant increase (p=0.07) in lactate dehydrogenase (LDH) release was 
observed in MWCNT-exposed asthmatic cells at w5. These findings support those recently 
reported in our previous study, where the effects of the same MWCNT type were 
investigated, upon short-term aerosol exposure into a 3D in vitro model of the human 
epithelial tissue barrier (A549 alveolar type II epithelial cells combined with two immune cell 
types).25 Thurnherr et al. compared the long-term effects of exposure to MWCNT suspensions 
to their acute effects, using the A549 cell line, demonstrating that long-term accumulation of 
CNTs did not influence either cell viability or morphology.13 In line with our findings, 
Ryman-Rasmussen et al. observed no changes in LDH release in both healthy and allergic 
(ovalbumin (OVA)-sensitized) asthmatic mice following a 6h MWCNT inhalation, although 
increased inflammation and fibrosis was identified.40 No significant cytotoxicity was observed 
for cells exposed to aerosolised Pluronic or DQ12 at any of the tested time-points. 
The ciliary mechanism of the bronchial epithelium following five weeks of repeated 
exposures was assessed by MCC and cilia beating frequency (CBF) analysis. The velocity of 
MCC in MWCNT-exposed healthy cells at w5 did not show any difference to those of the 
negative controls. Nevertheless, a significant increase (p<0.05) was measured in MWCNT-
treated asthma cultures at the same time-point (Figure 4c). In addition, long-term exposure to 
MWCNTs resulted in significant CBF increase in both healthy and asthmatic cells, when 
compared to control cultures (Figure 4d). Alterations of this self-defense mechanism can 
contribute to the pathogenesis of serious lung diseases e.g. cystic fibrosis and primary ciliary 
dyskinesia.41 A number of studies also hypothesized that different stress factors or 
physicochemical properties of NPs can result in increased CBF and MCC.42-44 Of note, 
comparing the impact of a five week MWCNT exposure in MCC and CBF activity between 
asthma and healthy cultures, no significant effect was shown for MCC. CBF however, was 
found significantly elevated in asthma tissues, giving a first indication of the potential adverse 
effects of chronic MWCNT exposure. 
 
 
 
 
Figure 4: Cellular morphology, cytotoxicity and cellular functionality following sub-
chronic repeated MWCNT exposure in healthy and asthma cells. (a) Confocal LSM 
images of healthy and asthmatic human bronchial epithelial cells exposed repeatedly for five 
weeks to aerosolised MWCNTs (scale bars: 20µm). Magenta color shows F-actin 
(cytoskeleton), blue color shows DNA (cell nuclei), yellow represents cilia and white the tight 
junctions. (b) Cytotoxicity as estimated by quantification of LDH release in cell culture 
medium after repeated MWCNT administration for up to five weeks (data shown relative to 
negative controls, n=4). 0.2% Triton X-100 was used as positive control. (c) Velocity of 
mucociliary clearance and (d) cilia beating frequency measurements in healthy and asthmatic 
cells at w5 (n=3). Values were considered significant if p<0.05. Data are presented as the 
mean ± standard error of the mean (SEM). # represents a significant increase (p < 0.05) in 
healthy cultures compared to the negative control. * indicates statistical significance in 
asthmatic cells compared to the negative control (p < 0.05). § shows a statistical significant 
response (p < 0.05) of asthma cultures, when compared to healthy cultures at w5.  
 
Cell responses 
In order to test the applicability of the presented in vitro lung system, the repeated 
administration of aerosolised DQ12 in human bronchial epithelial cells was assessed, since we 
have shown previously that this material can induce (pro-)inflammatory reactions in a 3D 
human epithelial tissue model upon acute and short-term exposures.25,26 Repeated exposure to 
DQ12 caused a pronounced increase in HMOX-1 gene levels (Figure 5a) at all tested time-
points for both culture types, with the highest activity being observed at week 3. In addition, 
the SOD-2 gene was highly expressed in DQ12-exposed healthy cells at all time-points 
(Figure 5b), while only a moderate increase was detected in asthmatic cultures. Importantly, 
induction of (pro-)inflammatory response was demonstrated in both healthy and asthma 
cultures. In healthy cells, all tested (pro-)inflammatory markers were increased even after 
week 1. Chronic repeated exposure to DQ12 for five weeks elicited a pronounced secretion of 
all tested cytokines for both healthy and asthma cultures when compared to control cultures. 
In particular, asthmatic cells revealed a significant response (p<0.05) in TGF-β compared to 
negative control (SI Figure 5d). Multiple animal studies confirmed the inflammatory 
properties of DQ12.45 Indeed, DQ12-exposed animals have been observed to express severe 
inflammatory effects following either 14d or 90d of exposure respectively.46,47 Therefore, the 
ability of DQ12 to trigger (pro-)inflammatory reactions at both gene and protein level 
highlights the effectiveness of the employed in vitro chronic strategy. Notably, the highest 
cytokine expression in DQ12-exposed cells was observed at w3 followed by a decrease over 
the last week, indicating a possible cell threshold or recovery from the repetitive challenge 
with DQ12. This finding is supported by a recent in vivo study where intratracheal 
administration of DQ12 in mice lead to increased acute inflammation but limited sub-chronic 
inflammation following three months of exposure.48 
In vitro studies have reported oxidative stress in human lung epithelial cells upon exposure to 
MWCNTs.13, 49 Therefore, the possible induction of oxidative-stress-related biomarkers was 
examined in chronically MWCNT-exposed cultures. In fact, an increase in HMOX-1 
expression levels was detected over the weeks of MWCNT exposure at all tested time-points 
in healthy as well as in asthmatic cells, compared to the negative control (Figure 5a). At w1 
and w5 a significant HMOX-1 gene expression increase in asthmatic cells (18.14±10.9-fold 
and 22.6±10.8-fold respectively) was observed, which was not only significant compared to 
those of control cells, but also significantly higher than for MWCNT-exposed healthy 
cultures. Focusing on SOD-2, repeated healthy tissue exposure to MWCNTs did not change 
the expression profile of this oxidative stress marker at w1. However, a slight increase 
(3.73±2.2) was observed at w3, followed by a strong increase (79.2±45.1, p=0.07) at w5 
although not statistically significant (Figure 5b). Moreover, higher SOD-2 response was 
obtained at all tested time points in exposed asthmatic cultures, with the highest activity 
reported at w5 (104.7±74.6, significant p<0.05). As shown for the HMOX-1 gene, diseased 
cells showed stronger SOD-2 effects compared to healthy cultures at w5. Overall, long-term 
MWCNT exposure resulted in an augmented oxidative stress response which was 
considerably stronger during the final week of exposure in both normal and diseased cultures. 
Similarly, a notable decrease in intracellular glutathione levels (GSH) was observed during 
our earlier study after short-term repeated exposure to the same material.25 In particular, 
oxidative stress has been proposed as the possible underlying mechanism by which CNTs 
exacerbate asthma in animal studies.22,23, 50 Indeed, the observed oxidative stress response was 
more pronounced in asthmatic tissues, thus further supporting the in vivo observations.  
 
       
Figure 5: Cellular response to oxidative stress upon long-term exposure to MWCNTs. 
Real-time RT-PCR on (a) HMOX-1 and (b) SOD-2 gene expression levels (n=4). Values were 
considered significant if p<0.05. Data are presented as the mean ± standard error of the mean 
(SEM). # represents a significant increase (p < 0.05) in healthy cultures compared to the 
negative control. * indicates statistical significance in asthmatic cells compared to the 
negative control (p < 0.05). § shows a statistical significant response (p < 0.05) of asthma 
cultures, when compared to healthy cultures at w5.  
 
Analysis of -the IL-8 expression, a critical airway epithelial-derived (pro-)inflammatory 
chemokine primarily implicated in acute inflammation and accumulation of neutrophils in 
inflammatory diseases51, revealed an increase in both healthy and asthmatic MWCNT-
exposed cells (Figure 6a). In particular, after the final experimental week a notable increase 
was shown for healthy tissues (9.2±1.99; p=0.06), while asthma cultures reported the highest 
IL-8 activity (26.4±7.9). The results obtained for the protein level reflect a similar pattern. 
Healthy as well as asthmatic cells exposed repeatedly to MWCNTs showed an increase in 
secreted IL-8 at all exposure times, although not significant compared to control cultures (SI 
Figure 5a). IL-6 is considered a key inflammatory marker (in both acute and chronic 
inflammation) with a potentially pivotal role in the pathogenesis and exacerbation of several 
lung diseases and in particular in asthma.52 In fact, recent findings have shown a correlation 
between IL-6 and human asthma, indicating an active role of IL-6 in the asthmatic altered 
bronchial lung function.53 An evident IL-6 gene induction, as well as release of the protein, 
was measured after five weeks of exposure in both healthy and asthmatic epithelium, although 
for both cell types this effect was not statistically significant (p<0.05) (Figure 6b, SI Figure 
5b). Similar observations were obtained for IP-10 and TGF-β gene expression after repeated 
MWCNT exposure. At w5, healthy and asthmatic cultures reported significant expression 
levels for IP-10 as well as pronounced effects for TGF-β. Of interest, increased IP10 
production has been associated with airway inflammation and hyper-responsiveness, resulting 
in asthma-related effects in animal studies.54 In addition, recent evidence have shown that 
enhanced TGF-β activity may contribute markedly to airway epithelial tissue damage, mucus 
hyper-secretion and airway remodeling, all key characteristics of a diseased i.e. asthma lung 
phenotype.55,56 Protein levels for both cytokines showed an elevated, but insignificant release 
at the tested time-points in comparison to the negative controls, independent of the culture 
type. Although the cytokine and chemokine protein levels reflect a similar trend with the 
gene expression analysis, the increased observed transcriptional gene activity resulted in a 
lower cytokine secretion which could potentially be explained by the time-frame required 
between the gene transcription and the proteins synthesis/secretion, by post-transcriptional 
regulations or by possible protein degradation.  
Regarding the potential impact of the dispersant in the cellular system, it is worth noting that 
although some effects were observed in cultures exposed to Pluronic F127, i.e. elevated 
expression of oxidative stress markers as well as induction of (pro-)inflammatory cytokines, 
the response was not as strong as in MWCNT-exposed cells, indicating that the effects 
observed following MWCNT exposure are mainly relevant to the MWCNTs themselves and 
not due to the surfactant coating. 
Shvedova et al. reported significant changes in the expression profiles of crucial biomarkers 
(including elevated IL-6 and TGF-β) associated with pulmonary and cardiovascular risk in 
blood samples from exposed workers in a MWCNT production facility.5 The (pro-
)inflammatory potential of long-term MWCNT exposure was assessed by evaluating the 
activity of classical toxicological indicators (IL-8, IL-6, IP-10 and TGF-β) that are well-
known for their ability to initiate (pro-)inflammatory and (pro-)fibrotic responses and further 
activate other involved (pro-)inflammatory mediators.32, 52 Repeated occupationally relevant 
MWCNT exposure elicited an enhanced, sustained and concentration-dependent (pro-
)inflammatory reaction in both healthy and asthmatic exposed cultures, with the highest 
activity observed in the final week. Acute in vitro deposition of MWCNTs onto the MucilAir 
bronchial epithelial tissue resulted in similar observations, such as induction of various (pro-
)inflammatory cytokines and ROS production, with absence of cytotoxic effects.57 Increased 
IL-6 expression was also demonstrated in mice repeatedly exposed to MWCNTs at doses 
relevant to 7.6 and 76 years of occupational exposure.3 In accordance with our findings, 
induction of IL-6, TGF-β and IFN-γ (activator of IP-10) was reported in healthy and OVA-
sensitized asthmatic mice upon exposure to single-walled CNTs (SWCNTs) and MWCNTs.22, 
40, 50  
By assessing pivotal (pro)-inflammatory parameters, it has been possible to gain a clear 
indication of the inflammatory potential of MWCNTs in a more realistic and advanced in 
vitro cellular and exposure system, under the presented chronic occupational test conditions. 
The substantial and duration dependent (pro-)inflammatory response can be the result of 
ongoing inflammation in the tissues.  
 
         
 
Figure 6: (Pro-)inflammatory response in cells exposed repeatedly to MWCNTs for up 
to five weeks. Gene expression levels of (a) IL-8, (b) IL-6 (c) IP-10 and (d) TGF-β at w1, w3 
and w5 time-points (n=4). TNF-α (1µg/ml) was used as positive control for IL-8 and IL-6 
induction, and IFN-γ (1µg/ml) for IP-10 and TGF-β, respectively. Values were considered 
significant if p<0.05. Data are presented as the mean ± standard error of the mean (SEM). # 
represents a significant increase (p < 0.05) in healthy cultures compared to the negative 
control.* indicates statistical significance in asthmatic cells compared to the negative control 
(p < 0.05).  
 
The effects of multiple functional, oxidative stress and (pro-)inflammatory parameters from 
asthma patients was shown to be greater than the effects on non-asthmatic. Given the 
importance of the assessed biological markers in the pathogenesis and exacerbation of asthma, 
our findings suggest a possible predisposition of asthmatic individuals to be more sensitive to 
the effects of chronic occupational MWCNT exposure. The exact mechanisms underlying the 
MWCNTs-induced chronic effects on the function and expression of mediators of 
reconstituted primary bronchial epithelium on asthmatic and non-asthmatic subjects however 
are not entirely clear. 
It is worth noting that experimental animals do not naturally develop asthma, therefore the 
disease has to be artificially induced by an antigen/allergen challenge, which sometimes does 
not portray the truest of pictures regarding human lung disease.39 Thus, an additional 
advantage of our alternative strategy is the use of human cells derived from asthmatic 
individuals.  
Overall, considering that the mechanisms of asthma are complex and that various factors are 
involved in the development and provocation of the disease, the findings provide a valuable 
indication that asthma cultures are probably more susceptible to MWCNTs in a long-term 
scenario. Taken together the observed findings, results revealed potential health risks 
associated with human occupational lifetime exposure to inhaled MWCNTs. 
 
 
 
 
 
 
CONCLUSIONS 
Due to the inevitable human exposure to aerosolised CNTs, mainly during their production 
and handling, it is imperative to investigate potential adverse effects following long-term, 
repeated occupational exposures. In the present study we have proven the reliability of an air-
liquid exposure system for aerosol exposure onto normal and diseased human primary cells, 
providing an effective platform to investigate possible risks after chronic nanofibre exposure, 
therefore presenting a more realistic and valid alternative to mimic the chronic inhalatory 
hazard of nanomaterials in vitro. Chronic MWCNT exposure elicited a duration-dependent 
(pro-)inflammatory and oxidative stress response as well as a significant alteration of the 
mucociliary clearance mechanism in both healthy and asthmatic cultures, under the presented 
experimental conditions. The latter revealing stronger and more durable long-term effects 
compared to healthy cells, indicating that individuals with asthma may be more prone to 
adverse effects from MWCNT exposure compared to non-asthmatic populations. In 
conclusion, the present study clearly indicates that there is an urgent need to develop more 
reliable and relevant predictive in vitro systems to assess adverse effects of sub-chronic 
exposed NMs in healthy and susceptible persons.  
 
MATERIALS AND METHODS 
Chemical and Reagents	
All chemicals and reagents used were obtained from Sigma-Aldrich (Switzerland), unless 
otherwise stated. 	
 
Human Reconstituted Bronchial Epithelium 
Fully differentiated primary human bronchial epithelial cells (MucilAirTM) obtained from 
bronchial biopsies from non-smoking, healthy (without respiratory pathologies) and asthmatic 
donors were purchased from Epithelix (Epithelix Sàrl, Geneva, Switzerland) and cultured 
according to supplier’s instructions. Briefly, cells were cultured at the ALI, in 24-well 
Transwell® inserts (6.5mm diameter, 0.4 µm pore size, Corning Incorporated, Massachusetts, 
USA) with MucilAir serum-free culture medium (0.7ml) (Epithelix Sàrl, Geneva, 
Switzerland; supplemented with 5µg/ml Posaconazole (Sigma-Aldrich, Switzerland)), on the 
basal side. Cell cultures were maintained at 37ºC, 5% CO2 for a period up to six weeks (i.e. 
one week prior to experimentation; up to five weeks of exposure). Cell culture media was 
changed every 2-3d. The apical side was washed with MucilAir medium at the end of each 
week, to remove mucus, surface dead cells and non-internalised MWCNTs, as recommended 
by the supplier. The tissue isolation was conducted according to the declaration of Helsinki on 
biomedical research (Hong Kong amendment, 1989), and received approval from local ethics 
commission. 
 
Characterisation of asthmatic cultures 
In order to demonstrate that asthma tissues preserve the asthmatic phenotype the release of 
GM-CSF was assessed in both negative control healthy and asthmatic tissues at w1, using the 
commercially available DuoSet ELISA Development Kit (R&D Systems, Switzerland) and 
following the supplier’s protocol.  
 
 MWCNTs and positive controls 
In order to obtain a well-dispersed and stable suspension, MWCNTs (Cheaptubes Inc., USA) 
were dispersed in Pluronic F127 (160ppm) as previously described.27 MWCNT stock 
suspension was thoroughly characterised by Thurnherr et al. and Clift et al. in terms of 
morphology, length, diameter, metal impurities (%wt) and endotoxin level.27, 30 The size 
distribution (length and width) of these MWCNTs following aerosolisation was reported 
previously.25 
To monitor the biological effects of the dispersant, cell cultures exposed to aerosolised 
Pluronic F127 (at 160ppm) were tested with all biochemical endpoints used. In addition, 
aerosolised crystalline Dörentruper Quartz (DQ12; ≤ 5 µm58, at 0.2µg/cm²) was employed as a 
positive (pro-)inflammatory particle control.46 
 
Air-Liquid Interface Cell Exposure System (ALICE) 
Aerosolisation of MWCNTs was performed using the ALICE system21, as reported by 
Chortarea et al.25 Briefly, the exposure system consists of a nebuliser, an exposure and an 
incubation chamber (connected to an air-flow system that provides optimum humidity and 
temperature conditions required for cell cultivation) as well as a QCM (operated at 5 MHz, 
detection limit: 0.09μg/cm2, Stanford Research Systems, GMP SA, Renens, Switzerland) for 
online measurements of the deposited dose. For each aerosolisation, 1ml of well-dispersed 
MWCNT suspension (250μg/ml) with 500µM NaCl (NAAPREP® physiological saline, 
GlaxoSmithKline, France) was added to the nebuliser (customized eFlow nebuliser system, 
PARI Pharma GmbH, Germany). The vibrating perforated membrane of the nebulizer then 
generates the aerosol, which is transported into the exposure chamber. Inside the chamber, it 
gently deposits the aerosolised MWCNT suspension onto cells that are maintained at the ALI. 
The selected flow rate (5L/min) is ideal for the aerosol to sufficiently mix to all sides of the 
chamber, hence resulting in uniform droplet deposition.  
 
Exposure experiments 
To address the potential biological impact of a lifetime of occupational MWCNT exposure on 
healthy and asthmatic cell cultures, cells were exposed for up to five weeks, five days per 
week (from Monday to Friday) to aerosolised MWCNTs using the ALICE system. The 
cellular response following MWCNT exposure was analyzed at three defined time-points; 
after w1, w3 and w5 (Figure 1).  
 
Characterisation of MWCNT deposition 
Material deposition was quantified by the incorporated QCM. Briefly, the deposited MWCNT 
dose was determined by the linear decrease in the resonance frequency of the vibrating 
piezoelectric crystal, due to increasing deposited mass. The differences in the frequency of the 
QCM, prior to and after aerosolisation were recorded and subsequently calculated to 
determine the mass per surface area (µg/cm²), as previously reported by Lenz et al.21 
 
To examine the morphology of the deposited MWCNT aerosols, TEM copper grids or SEM 
holders were exposed to aerosolised particles using the ALICE system. Representative images 
of deposited MWCNTs after a single exposure (d1) and five exposures (w1) were captured 
using TEM (Fei Technai Spirit (Oregon, USA)), operating at 120kV. Images were recorded 
with a Veleta CCD camera (Olympus, Japan). SEM samples were coated with a 4nm gold 
layer to improve electrical conductivity. Images were taken with a Tescan Mira3 LM FE 
(Czech Republic) at 4kV, working distance of 6mm and secondary electron mode. 
 
Interaction of MWCNTs with human bronchial epithelial cells 
The MWCNT-lung cell interaction following repeated exposures at w1, w3 and w5, was 
investigated by TEM. Sample preparation was performed as previously described.59 Briefly, 
the exposed cells were fixed with 2.5% glutaraldehyde in HEPES buffer, then post-fixed with 
1% osmium tetroxide and stained with 0.5% uranyl acetate. Following dehydration in a 
graded ethanol series, samples were embedded in epon. Embedded cells were cut into 
ultrathin sections (50-80nm), mounted on copper grids and finally stained with uranyl acetate 
and lead citrate. Images were recorded using TEM (Fei Technai Spirit (Oregon, USA)), 
operating at 120 kV with a Veleta CCD camera (Olympus, Japan). 
 Cytotoxicity 
As an indicator of cell membrane damage60, the release of LDH into the supernatant was 
assessed using a LDH cytotoxicity detection kit (Roche Applied Science, Mannheim, 
Germany), according to the manufacturer’s protocol. Each sample was tested in triplicate on 
four independent occasions (n=4) and evaluated against the negative control. Quantification 
of LDH activity was performed photometrically by measuring at 490nm (reference 
wavelength at 630nm). For positive controls, cell cultures were exposed apically to 0.2% 
Triton X-100 in PBS for 24h. 
 
Cell morphology 
Cell cultures were fixed for 15min in 3% paraformaldehyde (PFA) at room temperature and 
treated with 0.1 M glycine in PBS for another 15min. Subsequently, fixed cells were 
permeabilised in 0.2% Triton X-100 in PBS for 15min at room temperature. Antibodies were 
diluted in 0.3% Triton X-100 and 1% BSA in PBS. Mouse anti-alpha tubulin (Sigma-Aldrich, 
Switzerland; 1:100 dilution) was used to stain the epithelial cilia and rabbit anti-zonula 
occludins (ZO)-3 (Sigma-Aldrich, Switzerland; 1:50 dilution) for staining the tight junctions. 
Secondary antibodies were goat anti-mouse Alexa 488 (Abcam, Cambridge, UK; 1:200 
dilution) and goat anti-rabbit Dylight 650 (Millipore, Darmstadt, Germany; 1:200 dilution) 
respectively. F-actin cytoskeleton was labelled with Phalloidin rhodamine (R-415; Molecular 
Probes, Life Technologies Europe B.V., Zug, Switzerland; 1:50 dilution, whilst the nucleus 
was stained with DAPI (1µg/ml; Sigma Aldrich, Switzerland). Samples were incubated with 
primary and then secondary antibodies for 2h at room temperature. Following incubation, the 
samples were embedded in Glycergel (DAKO Schweiz AG, Baar, Switzerland). Cell 
visualisation was performed using an inverted LSM 710 (Axio Observer.Z1, Carl Zeiss, 
Germany). Image processing was achieved by using the 3D restoration software IMARIS 
(Bitplane AG, Zurich, Switzerland). Additionally, the morphology of the bronchial epithelium 
was also observed using a conventional light microscope (AE200, Motic, Switzerland) 
containing a digital camera (Nikon, Switzerland).	
	
Cilia beating frequency (CBF) 
Cell cultures (at the w5 time point only) were visualized using an Axiovert 200M microscope 
(Carl Zeiss, Germany) connected to a Sony XCD V60 Firewire camera. A total 256 images of 
the cultures were recorded per insert and CBF was then calculated using Cilia FA software as 
described by Smith et al.61 Each condition was tested in triplicate on four independent 
occasions (n=4).  
 
Mucociliary Clearance (MCC) 
For the MCC measurements, 30µm polysterene microbeads (Sigma-Aldrich, Switzerland) 
were added to the apical surface of the epithelial cells (w5). Cells were monitored using a 
high speed acquisition camera (Sony) connected to an Axiovert 200M microscope (Carl Zeiss, 
Germany). The movement of the micron-sized beads were captured on 60-second movies (4 
movies per insert). Tracking analysis was performed using imaging software Image Pro Plus 
(Mediacy, Rockville, USA) in order to calculate the velocity of the bead clearance. An 
average number of 300 beads were tracked per insert. Samples were tested in triplicate. 
 
Gene expression analysis of oxidative stress and (pro-)inflammatory markers 
Following w1, w3 and w5, the insert membranes were transferred into RNA-Protect cell 
reagent (Qiagen AG, Hombrechtikon, Switzerland) and stored at 4°C until further processing. 
RNA was isolated using the RNeasy plus kit (Qiagen) according to manufacturer’s manual 
and RNA concentration was determined by a NanoDrop 2000 (Thermo Scientific, Witec AG, 
Littau, Switzerland). The reverse transcriptase reactions were performed with the Omniscript 
RT system and Oligo dT primers (Qiagen) as described by Bisig et al.62 Real-time PCR was 
carried out using the 7500 Fast Real-Time PCR system, (Applied Biosystems, Life 
Technologies Europe B.V., Zug, Switzerland) using Fast SYBR Green Master Mix (Applied 
Biosystems) as a reporter dye. The relative expression levels were subsequently calculated 
using the ΔΔCt method as described by Schmittgen et al.63  Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) acted as the internal standard gene. Oxidative stress markers 
HMOX-1 and SOD-2 were assessed for oxidative stress. To examine (pro-)inflammatory 
responses, the IL-8, IL-6, IP-10 and TGF-β genes were evaluated. The primer sequences for 
all tested genes can be found in supporting information (Supplementary Table 2). 
 
(Pro-)inflammatory cytokine secretion 
The (pro-)inflammatory response was also investigated by quantifying the amount of the (pro-
)inflammatory mediators IL-8, IL-6, IP-10 and TGF-β by using the commercially available 
DuoSet ELISA Development Kit (R&D Systems, Switzerland) according to the supplier’s 
manual. Cell cultures treated apically with Tumor Necrosis Factor-α (TNF-α; 1µg/ml;	
Immunotools, Germany) and Interferon-γ (IFN-γ; 1µg/ml; Immunotools, Germany) for 24h 
served as positive controls for the induction of a (pro-)inflammatory response. 
 
Statistical analysis 
All data are presented as the mean±standard error of the mean (SEM). Statistical analysis was 
conducted using GraphPad Prism 6 (GraphPad Software Inc., La Jolla, USA). An independent 
two-sided Student’s t test was performed. Values were considered significant if p<0.05. All 
endpoints were evaluated at four different repetitions (n=4), except MCC and CBF 
measurements (n=3). 
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